Home › NDC Lookup › RxCUI directory › RxCUI 1726676

Bleomycin 30 UNT Injection — RxCUI 1726676

RxNorm drug concept · Semantic clinical drug
RxCUI 1726676 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1726676
Official nameBleomycin 30 UNT Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbleomycin (as bleomycin sulfate) 30 UNT Injection
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)918 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bleomycin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Bleomycin is a chemotherapy drug used to treat certain cancers — mainly squamous cell carcinomas (like those in the head and neck, cervix, or penis), lymphomas like Hodgkin's disea...
  • No, bleomycin is always given by injection — never as a pill. Depending on your condition, it might go into a vein, a muscle, under the skin, or directly into your chest cavity. Yo...
  • How will I receive bleomycin — will I take a pill at home?
  • Skin changes are very common — things like darkening, rash, blistering, nail changes, and hair loss affect roughly half of patients. Fever, chills, mouth sores, and appetite loss a...
📖 Read our full Bleomycin guide →

🕸️ Concept Web — How Bleomycin 30 UNT Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bleomycin 30 UNT Injection RxCUI 1726676

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bleomycin 1622
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bleomycin Injection 1726672
    • Bleomycin Injectable Product 1154720
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Bleomycin 30 UNT 1726675

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bleomycin 30 UNT SCDC · 1726675
  • Bleomycin Injection SCDF · 1726672
  • Bleomycin Injectable Product SCDG · 1154720

📦 FDA Products & Package NDCs

12 products · 12 package NDCs
12 package NDCs map to RxCUI 1726676 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9240-01 1 VIAL in 1 BOX, UNIT-DOSE (0143-9240-01) / 1 INJECTION, PO... Bleomycin Hikma Pharmaceuticals USA Inc. 2018-01-09
00143-9241-01 1 VIAL in 1 BOX, UNIT-DOSE (0143-9241-01) / 1 INJECTION, PO... Bleomycin Hikma Pharmaceuticals USA Inc. 2018-01-09
00409-0323-20 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0323-20) / 1 INJECTIO... Bleomycin Hospira, Inc. 2018-04-25
00409-0332-20 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0332-20) / 1 INJECTIO... Bleomycin Hospira, Inc. 2018-04-25
16714-0886-01 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-886-01) / 15 POWDER,... Bleomycin NorthStar Rx LLC 2018-12-01
16714-0908-01 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-908-01) / 30 POWDER,... Bleomycin NorthStar Rx LLC 2018-12-01
61703-0323-22 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-323-22) / 1 INJECTIO... Bleomycin Hospira, Inc. 2000-04-10
61703-0332-18 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-332-18) / 1 INJECTIO... Bleomycin Hospira, Inc. 2000-04-11
63323-0136-10 1 VIAL in 1 CARTON (63323-136-10) / 1 INJECTION, POWDER, LY... Bleomycin Fresenius Kabi USA, LLC 2009-02-13
63323-0137-20 1 VIAL in 1 CARTON (63323-137-20) / 1 INJECTION, POWDER, LY... Bleomycin Fresenius Kabi USA, LLC 2009-02-13
71288-0106-10 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-106-10) / 15 POWDER,... Bleomycin Meitheal Pharmaceuticals Inc. 2018-08-31
71288-0107-20 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-107-20) / 30 POWDER,... Bleomycin Meitheal Pharmaceuticals Inc. 2018-08-31
Observed labelers: Hospira, Inc. (4) · Fresenius Kabi USA, LLC (2) · Hikma Pharmaceuticals USA Inc. (2) · Meitheal Pharmaceuticals Inc. (2) · NorthStar Rx LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9040 Bleomycin sulfate injection 12 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.